A STUDY ON ASSESSMENT OF DEPRESSION AND SLEEP DISTURBANCES AMONG PATIENTS WITH RHEUMATOID ARTHRITIS
AbstractThe prevalence of Rheumatoid Arthritis is 0.1% to 1% and it is most common in developed countries. More than 2/3rd [54%-70%] of patients with RA have sleep disturbances. In RA multiple episodes of inflammation are predictive of an increased risk of developing depression. The prevalence of depression in individual RA ranges 14% to 48%. Sleep disturbances & depression in those with RA patients worsen their quality of life and impair their daily activity. Sleep issues and depressions have the potential to disrupt the effectiveness of treatments for RA. By addressing their concerns, we can enhance treatment compliance. There is a bidirectional relationship between RA, sleep disturbance & depression, poor sleep and depression can worsen RA symptoms. Understanding this complex scenario is crucial for the comprehensive care. Identifying and addressing sleep problems & depression can lead to better management strategies. These may involve lifestyle changes medication adjustments or mental health interventions to improve both physical & emotional well-being. This study is essential for enhancing their wellbeing, optimizing treatment outcomes and providing comprehensive care.
Article Information
27
3359-3370
740 KB
75
English
IJPSR
Nanda Gopala Krishna Gona *, Sony Priyanka Arava, Bhargavi Pacchipala, Alekhya Somepalli and Chanukya Senapathi
Department of Pharmaceutical Analysis, A. S. N. Pharmacy College, Burripalem Road, Tenali, Andhra Pradesh, India.
gona1689@gmail.com
22 May 2024
16 July 2024
21 October 2024
10.13040/IJPSR.0975-8232.15(11).3359-70
01 November 2024